SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-001404
Filing Date
2018-02-06
Accepted
2018-02-06 16:15:25
Documents
3
Period of Report
2018-02-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20180206.htm 8-K 25610
2 EX-99.1 vktx-ex991_6.htm EX-99.1 14949
3 GRAPHIC g2018020619591866666810.jpg GRAPHIC 4119
  Complete submission text file 0001564590-18-001404.txt   47479
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 18577774
SIC: 2834 Pharmaceutical Preparations